Drug development for neglected diseases - the trouble with FDA review vouchers.
Kesselheim
Aaron S
AS
Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital, Harvard Medical School, Boston, USA.
D003906:Developing Countries; D017277:Drug Approval / Q000191:economics / Q000331:legislation & jurisprudence* / Q000379:methods; D055808:Drug Discovery / Q000331:legislation & jurisprudence*; D004345:Drug Industry; D033161:Government Regulation; D006291:Health Policy / Q000191:economics; D006801:Humans; D010272:Parasitic Diseases / Q000188:drug therapy*; D014330:Tropical Medicine; D014481:United States; D014486:United States Food and Drug Administration